Homocysteine levels in patients with deep vein thrombosis lacking thrombophilic defects
Authors:
- 1 January 2008
- journal article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 99 (06) , 1132-1134
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Hyperhomocysteinemia and Venous ThrombosisSeminars in Hematology, 2007
- The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defectsThrombosis and Haemostasis, 2007
- Hyperhomocysteinemia and Venous ThromboembolismSeminars in Thrombosis and Hemostasis, 2006
- Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trialBlood, 2006
- Hyperhomocysteinemia: cause or effect of disease?Blood, 2005
- Homocysteine, MTHFR and risk of venous thrombosis: a meta‐analysis of published epidemiological studiesJournal of Thrombosis and Haemostasis, 2005
- Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart StudyBlood, 2004
- Biological and Environmental Determinants of Plasma HomocysteineSeminars in Thrombosis and Hemostasis, 2000
- An alternative view of homocysteineThe Lancet, 1999
- Dietary habits and geographic variation in stomach cancer mortality in SpainEuropean Journal Of Cancer Prevention, 1996